Daboxin P, a phospholipase A2 of Indian Daboia russelii venom, modulates thrombin-mediated platelet aggregation

J Biochem Mol Toxicol. 2023 Nov;37(11):e23476. doi: 10.1002/jbt.23476. Epub 2023 Jul 19.

Abstract

Daboxin P, reported earlier from the venom of Daboia russellii, disturbs the blood coagulation cascade by targeting factor X and factor Xa. The present study exhibits that Daboxin P also inhibits platelet aggregation induced by various agonists. The thrombin-induced platelet aggregation was inhibited maximum whereas inhibition of collagen-induced platelet aggregation was found to be 50% and no inhibition of adenosine diphosphate (ADP) and arachidonic acid-induced aggregation was observed. Daboxin P dose-dependently inhibited the thrombin-induced platelet aggregation with Anti-Aggregation 50 (AD50 ) dose of 55.166 nM and also reduced the thrombin-mediated calcium influx. In-silico interaction studies suggested that Daboxin P binds to thrombin and blocks its interaction with its receptor on the platelet surface. Quenching of thrombin's emission spectrum by Daboxin P and electrophoretic profiles of pull-down assay further reveals the binding between Daboxin P and thrombin. Thus, the present study demonstrates that Daboxin P inhibits thrombin-induced platelet aggregation by binding to thrombin.

Keywords: Daboxin P; Russell's viper venom; phospholipase A2 enzyme; protease-activated receptors; thrombin inhibitor; thrombin-induced platelet aggregation.

MeSH terms

  • Blood Coagulation
  • Blood Platelets
  • Phospholipases A2 / pharmacology
  • Platelet Aggregation*
  • Thrombin* / pharmacology
  • Viper Venoms / pharmacology

Substances

  • Thrombin
  • Phospholipases A2
  • Viper Venoms